Company Name CeraPedics
Mailing Address 11025 Dover Street Westminster, CO 80021
Company Description CeraPedics, Inc. is developing and commercializing products for the orthopedic bone substitutes market. The Company’s products utilize a proprietary small peptide called P-15. CeraPedics’ products should provide a safe, efficacious, and economical alternative to autograft and recombinant bone growth factor products for most procedures requiring a bone graft including spine fusion, trauma, and joint reconstruction.
Proceeds Purposes Proceeds will be used to support the company’s ongoing activities with its current Investigational Device Exemption (IDE) clinical trial in the United States studying its i-FACTOR(TM) peptide enhanced bone graft for cervical spine applications and prepare for commercialization upon FDA approval.